Recipharm Invests in its Single Dose Nasal Platform Capabilities
Recipharm, a global contract development and manufacturing organisation
(CDMO), has announced that it is expanding its capabilities for its
proprietary Unidose® Xtra (single dose) nasal delivery platform. More info >>
Successfully managing the unique demands of cell therapy supply chains
PCI Pharma Services
Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event. More info >>